Q3 2019 Holdings
Filed 2019-11-14 | 18 holdings | $146.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $26.8K | 403,688 | 18.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $22.6K | 287,205 | 15.4% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $17.0K | 1,726,603 | 11.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $14.7K | 676,602 | 10.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $13.6K | 522,637 | 9.3% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $10.8K | 383,480 | 7.4% |
| Sutro BioPharma Inc | COM | 869367102 | $10.2K | 1,125,579 | 7.0% |
| Atreca Inc(BCELUSD) | COM | 04965G109 | $7.2K | 591,368 | 4.9% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $6.3K | 376,583 | 4.3% |
| Hookipa Pharma Inc | COM | 43906K100 | $4.0K | 530,245 | 2.7% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $3.3K | 442,733 | 2.3% |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | $2.6K | 3,610,913 | 1.8% |
| Catabasis Pharmaceuticals Inc(CATBEUR) | COM | 14875P206 | $1.6K | 300,000 | 1.1% |
| Urovant Sciences Ltd | COM | G9381B108 | $1.5K | 157,480 | 1.0% |
| Evelo Biosciences Inc | COM | 299734103 | $1.4K | 227,529 | 0.9% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.4K | 118,500 | 0.9% |
| Millendo Therapeutics Inc | COM | 60040X103 | $1.3K | 186,540 | 0.9% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $550 | 154,462 | 0.4% |